- Home
- SANA vs LAB Comparison
SANA vs LAB Comparison
Compare SANA & LAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SANA
- LAB
- Stock Information
- Founded
- SANA 2018
- LAB 1999
- Country
- SANA United States
- LAB United States
- Employees
- SANA N/A
- LAB N/A
- Industry
- SANA Medicinal Chemicals and Botanical Products
- LAB Biotechnology: Laboratory Analytical Instruments
- Sector
- SANA Health Care
- LAB Industrials
- Exchange
- SANA Nasdaq
- LAB Nasdaq
- Market Cap
- SANA 519.8M
- LAB 451.0M
- IPO Year
- SANA 2021
- LAB 2011
- Fundamental
- Price
- SANA $2.17
- LAB $1.01
- Analyst Decision
- SANA Strong Buy
- LAB Buy
- Analyst Count
- SANA 5
- LAB 2
- Target Price
- SANA $9.50
- LAB $2.50
- AVG Volume (30 Days)
- SANA 3.9M
- LAB 1.6M
- Earning Date
- SANA 05-08-2025
- LAB 05-06-2025
- Dividend Yield
- SANA N/A
- LAB N/A
- EPS Growth
- SANA N/A
- LAB N/A
- EPS
- SANA N/A
- LAB N/A
- Revenue
- SANA N/A
- LAB $169,687,000.00
- Revenue This Year
- SANA N/A
- LAB N/A
- Revenue Next Year
- SANA N/A
- LAB $12.18
- P/E Ratio
- SANA N/A
- LAB N/A
- Revenue Growth
- SANA N/A
- LAB 33.86
- 52 Week Low
- SANA $1.26
- LAB $0.92
- 52 Week High
- SANA $8.17
- LAB $2.65
- Technical
- Relative Strength Index (RSI)
- SANA 59.16
- LAB 44.66
- Support Level
- SANA $1.81
- LAB $1.00
- Resistance Level
- SANA $2.35
- LAB $1.09
- Average True Range (ATR)
- SANA 0.21
- LAB 0.08
- MACD
- SANA 0.05
- LAB -0.00
- Stochastic Oscillator
- SANA 76.00
- LAB 33.33
About SANA Sana Biotechnology Inc.
Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.
About LAB Standard BioTools Inc.
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.